Loading…
ATLRx, Inc. was cited for selling unapproved new drugs and misbranded products, including CBD and Delta-8 THC items (gummies, tinctures, capsules, and topicals) for human use that lacked FDA approval and proper labeling in violation of the Federal Food, Drug, and Cosmetic Act. The company also marketed unapproved and unsafe animal drugs including CBD pet oils and treats, as well as food products adulterated with CBD as an unsafe food additive. These violations were identified through FDA's review of the company's website and social media platforms (Twitter, Facebook, and Instagram) in February 2022, which directed consumers to purchase these products online.